EyeCRO Receives Full Accreditation from AAALAC International for its Research Facilities

ByPhotoreceptor

EyeCRO LLC has been awarded full accreditation from AAALAC International for their facility in Oklahoma City, OK. EyeCRO joins the Department of Veterans Affairs, the Oklahoma Medical Research Foundation, Oklahoma State University, and the University of Oklahoma Health Sciences Center as the fifth institution in Oklahoma to receive this prestigious endorsement. The award letter from AAALAC International stated: “Especially noteworthy were the strong administrative commitment to the program; the top-down commitment to a culture of care; the well written Program Description addressing all required elements; the well maintained and clean facilities; the thorough and well documented staff training; and the excellent veterinary medical care.

Read the entire article here.

Similar Posts

Retinopathy Prevalence Decreasing in Diabetic Adolescents

ByConnor Hodde

A 20-year observational study has chronicled notable declines in retinopathy for young patients with type 1 diabetes who receive intensive glycemic control therapy, confirming earlier findings that found a link between normalized blood glucose levels and the slower progression of eye, kidney, and nerve damage.  http://www.medscape.com/viewarticle/752133

Interim results from clinical trial demonstrate safety of cell-based therapy for retinitis pigmentosa

ByConnor Hodde

Regenerative medicine company jCyte and the Sue & Bill Gross Stem Cell Research Center at the University of California, Irvine report that their investigational therapy for retinitis pigmentosa (RP) has demonstrated a favorable safety and tolerability profile in an ongoing Phase I/II clinical trial.  The cell-based approach taken is intended to rescue sick and dying…

RetroSense Granted Orphan Drug Designation for Retinitis Pigmentosa

ByConnor Hodde

RetroSense Therapeutics, LLC, a privately-held biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation for the Company’s lead product RST-001 for the treatment of retinitis pigmentosa (RP). Retinitis pigmentosa is a genetic condition which leads to the progressive degeneration of rod and cone photoreceptors (cells found in…

Diabetic Retinopathy, Microalbuminuria Predict GFR Decline

ByConnor Hodde

Having diabetic retinopathy and/or microalbuminuria predicted a much higher rate of annual decline in glomerular filtration rate (GFR) in a new study of patients with type 2 diabetes living in Japan. Diabetic retinopathy is a known risk factor for microalbuminuria, and microalbuminuria is a risk factor for macroalbuminuria, but to date it has been unclear…

iPad Vision Test Big Hit With Macular Degeneration Patients

ByConnor Hodde

An overwhelming majority of people with age-related macular degeneration would rather test their vision with an iPad app than with traditional methods, a new study shows. “One of the major advantages of iPad testing is that patients are much more involved in their disease. They’re engaged,” Matthias Hartmann, MD, an ophthalmologist in private practice from…